International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

DM Wingerchuk, B Banwell, JL Bennett, P Cabre… - Neurology, 2015 - AAN Enterprises
Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple
sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies …

MRI characteristics of neuromyelitis optica spectrum disorder: an international update

HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum… - Neurology, 2015 - AAN Enterprises
Since its initial reports in the 19th century, neuromyelitis optica (NMO) had been thought to
involve only the optic nerves and spinal cord. However, the discovery of highly specific anti …

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

DK Sato, D Callegaro, MA Lana-Peixoto, PJ Waters… - Neurology, 2014 - AAN Enterprises
Objective: To evaluate clinical features among patients with neuromyelitis optica spectrum
disorders (NMOSD) who have myelin oligodendrocyte glycoprotein (MOG) antibodies …

Short myelitis lesions in aquaporin-4-IgG–positive neuromyelitis optica spectrum disorders

EP Flanagan, BG Weinshenker, KN Krecke… - JAMA …, 2015 - jamanetwork.com
Importance Short transverse myelitis (STM;< 3 vertebral segments) is considered
noncharacteristic of neuromyelitis optica (NMO) spectrum disorders (NMOSDs) …

Cell‐surface central nervous system autoantibodies: clinical relevance and emerging paradigms

SR Irani, JM Gelfand, A Al‐Diwani… - Annals of …, 2014 - Wiley Online Library
The recent discovery of several potentially pathogenic autoantibodies has helped identify
patients with clinically distinctive central nervous system diseases that appear to benefit from …

Differential diagnosis of neuromyelitis optica spectrum disorders

SM Kim, SJ Kim, HJ Lee, H Kuroda… - Therapeutic …, 2017 - journals.sagepub.com
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder of the central
nervous system (CNS) mostly manifesting as optic neuritis and/or myelitis, which are …

Treatment and outcome of aquaporin-4 antibody–positive NMOSD: a multinational pediatric study

RB Paolilo, Y Hacohen, E Yazbeck… - Neurology …, 2020 - AAN Enterprises
Objective To describe the clinical phenotypes, treatment response, and outcome of children
with antibodies against aquaporin-4 (AQP4-Ab) neuromyelitis optica spectrum disorder …

Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder

JW Hyun, IH Jeong, AR Joung, SH Kim, HJ Kim - Neurology, 2016 - AAN Enterprises
Objective: To evaluate the application of the 2015 International Panel for NMO Diagnosis
(IPND) criteria to consecutive cases of neuromyelitis optica spectrum disorder (NMOSD) in a …

AQP4 autoantibody assay performance in clinical laboratory service

JP Fryer, VA Lennon, SJ Pittock… - Neuroimmunology & …, 2014 - AAN Enterprises
Objective: To compare performance of contemporary aquaporin-4–immunoglobulin (Ig) G
assays in clinical service. Methods: Sera from neurologic patients (4 groups) and controls …

[HTML][HTML] Emerging roles for AQP in mammalian extracellular vesicles

CE Clarke-Bland, RM Bill, A Devitt - Biochimica et Biophysica Acta (BBA) …, 2022 - Elsevier
Recent research in the aquaporin (AQP) field has identified a role for diverse AQPs in
extracellular vesicles (EV). Though still in its infancy, there is a growing body of knowledge …